QBI was awarded $13.7 million by the California Institute for Regenerative Medicine (CIRM) to advance research into the molecular and neurodevelopmental basis of schizophrenia using stem cells, building on prior work in Autism commenced by the QBI Psychiatric Cell Map Initiative (PCMI). The research team, led by investigator Tomasz Nowakowski and comprised of leading scientists from UCSF, Stanford University, UCLA, and UCSD, released an initial atlas of protein interactions of high-confidence autism and neurodevelopmental disorders risk genes, and will now extend the work to stem cell derived models, and focus on schizophrenia risk variants.
